Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Valganciclovir for Oral Solution, 50 mg/mL. A press release being issued in this regard is enclosed.
The above information is a part of company’s filings submitted to BSE.